Announcements Trials

Browse Landscape

Phase

Status

Completed 15 Unknown 5 Recruiting 4 Withdrawn 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 487 Gastrointestinal 72 Breast 64 Genitourinary 50 Head & Neck 33 Gynecologic 28 Dermatologic 27 CNS 27 Sarcoma 19 Other solid neoplasm 11 Lymphoid 7 Endocrine 5 Plasma cell 4 Other hematologic neoplasm 4 Classical hematology 3 Myeloid 2 Other neoplasm 1 Other 1 NET 1

Conditions

Obesity 19 Mucositis 19 Constipation 13 Neoplasms 11 Opioid-Induced Constipation 9 Pain 8 Overweight 5 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Sexual Dysfunction, Physiological 4 Bronchiolitis Obliterans Syndrome 4 Xerostomia 3 Stomatitis 3 Radiation Injuries 3 Polycystic Ovary Syndrome 3 Breast Neoplasms 3 Sedentary Behavior 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Glucose Intolerance 2 Endometrial Neoplasms 2 Dyspnea 2 Chemotherapy-induced Peripheral Neuropathy 2 Venous Thromboembolism 1 Urinary Incontinence 1 Thyroid Diseases 1 Stomach Ulcer 1 Stomach Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Neoplasms × Other × Clear all

NCT02063828 2021-03-05

RELAX

Wake Forest University Health Sciences

Phase NA Terminated

46 enrolled 19 charts

Anxiety Disorders, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡